
Michael Kremer on Innovation
IMF Podcasts
The Limits on Pricing During a Pandemic
There's going to be social and political limits on pricing of essential drugs during pandemics. The commercial returns from developing innovations such as these will not match the social value. A sub-case of that is R&D for pandemic preparedness. And hence there's at least a potential case for public support for investing in these innovations.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.